Articles

Podcasts

Videos

Brexipiprazole has been previously approved for adults with schizophrenia and adults with major depressive disorder. 

FDA Approves Schizophrenia Drug for Patients Aged 13-17 Years

Between 20-30% of patients with schizophrenia do not respond to the first-line antipsychotic treatment. 

Genetic Data Explains Treatment Resistant Schizophrenia

Several risk factors including low education and unhealthy lifestyle choices are partially responsible for this projected increase, though investigators believe changes could be made to decrease the number of dementia cases.

Global Dementia Cases Expected to Triple by 2050

The University of Michigan School of Nursing DASH Center director discusses the impact and reach of adult prescription drug misuse.

Sean Esteban McCabe, PhD: The Burden of Prescription Drug Misuse in the US

A new survey analysis shows prescription opioid, stimulant, sedative and tranquilizer misuse is common by age 50, and is greatly associated with substance abuse disorder risk.

Study: Half of US Adults Report Prescription Drug Misuse

Previous research have focused mostly on adults or patients with other comorbidities.

Digital Therapies Targeting Neural Markers Beneficial for Children With ADHD

Burnout problems persisted prior to the COVID-19 pandemic, but have been made worse since the beginning of the pandemic. 

Biggest Challenges Nurses Faced In 2021 And How To Become More Resilient In The Future

Participants with at least 3 psychiatric disorders more likely had a family history of psychiatric disorders.

Extremely Preterm Births Linked to Increase Risk of Psychiatric Disorders

Complex ADHD along with other comorbid psychiatric conditions increases the risk of mortality for patients.

Theresa Cerulli, MD: Explaining Complex ADHD

The treatment is approved as either a monotherapy or an adjunctive therapy with either lithium or valproate. 

FDA Approves Lumateperone for Bipolar Depression

Addiction

Addiction medicine condition center page, resources on the topics of medical news and expert insight into clinical addiction can be found. Content includes articles, interviews, videos, podcasts, and breaking news on addiction therapy research, treatment, and drug development.

ADHD

ADHD condition center page is a comprehensive resource for clinical news and insights on ADHD. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for ADHD.

Bipolar Disorder

The HCPLive bipolar disorder page is a resource for medical news and expert insights on BPD. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for bipolar disease, and more.

Major Depressive Disorder

Major Depressive Disorder condition center page, resources on the topics of medical news and expert insight into depression can be found. Content includes articles, interviews, videos, podcasts, and breaking news on MDD research, treatment, and drug development.

Schizophrenia

The HCPLive schizophrenia page is a resource for medical news and expert insights on the mental disorder. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for schizophrenia, and more.

Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.